Hi Rainmaker, As more of a trader than investor I would rather INSV be acquired rather than issue shares to be a buyer. I don't think the company has the cash to buy a real player anywhere and that INSV by itself is enough of a crapshoot without adding another OTCBB company.
PS. I'd prefer the Nasdaq as a biotech company over the Amex anyway, so what's to keep them from applying? Their market cap?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.